Skip to content
Thursday, November 12, 2026
Markon Solutions provides professional IT consulting, digit…

Individuals Coming Off Anti-Obesity Injections Regain Pounds Far More Rapidly Than People Using Diet and Exercise

Image of medical syringe and weighing machine
Obesity treatment involves long-term strategies.

A recent study suggests that people who discontinue blockbuster slimming jabs like Mounjaro or Wegovy tend to recover lost weight much more quickly than those who end conventional lifestyle programs.

Published data in a major medical journal shows that while obese people frequently drop substantial amounts of their body weight while on the medication, the weight is regained at an average rate of 0.8 kg per month after stopping.

"People buying these treatments should be aware of the risk of fast weight regain when the treatment is stopped," warns researcher Dr. Susan Jebb.

That rate of recovery implies a reversion to starting weight in about one and a half years.

Comparing Treatments

The analysis, which looked at dozens of trials involving over 9,000 of patients, contrasted the outcomes of these new drugs with older methods.

The team emphasize that people who shed pounds through lifestyle changes alone typically see a less rapid creep back—around 100 grams monthly—once they finish.

The Reason for the Rapid Regain

Doctors suggest the mode of action of the jabs accounts for the heightened weight return.

These medications copy a natural hormone called GLP-1, which helps regulate appetite.

"Artificially providing GLP-1 concentrations several times higher than the body's typical production could lead to the system to produce less of its own natural hormone, and could diminish responsiveness to its effects," said Dr. Adam Collins, a dietetics specialist.

"Withdrawal of this medication leads to appetite is unsuppressed, making excessive eating much more probable."

A Chronic Condition?

The NHS recommend the jabs for individuals with obesity-related health risks, accompanied by prescribed lifestyle changes.

Many experts argue that, considering the likelihood of relapse, the therapy might need to be ongoing.

This perspective is supported by pharmaceutical companies, who say that the results "underscore the chronic nature of excess weight," similar to managing diseases like diabetes.

User Experiences

People who have stopped the medication explain a powerful resurgence of hunger.

"It felt as if something activating and I was suddenly ravenous," described one woman.

The struggle is exacerbated if users have not adopted lasting dietary or behavioural changes during treatment.

Widespread Interest

Survey data indicate that a significant number of people in the UK have used weight-loss jabs in the past year, with desire remaining high.

  • Use is higher among women compared to men.
  • The middle-aged age group shows the highest usage rates.
  • A large proportion obtain the medications through private prescriptions rather than the NHS.

Finally, experts caution that while the jabs are powerful agents for shedding pounds, they are not a magic cure and maintained weight loss relies on ongoing lifestyle support.

AW
By

Angela Wagner

A seasoned IT strategist with over 15 years of experience in digital transformation and cybersecurity, passionate about helping businesses leverage technology for competitive advantage.

Markon Solutions

Type to search articles.